Narcolepsy, Narcolepsy Type 1, Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, Nightmare, Nightmare Disorder With Associated Other Sleep Disorder
Conditions
Keywords
Imagery Rehearsal Therapy, Cognitive Behavioral Therapy for Nightmares
Brief summary
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
Interventions
The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. During the sessions, participants will learn techniques for managing and changing nightmares.
Sponsors
Study design
Intervention model description
Waitlist control
Eligibility
Inclusion criteria
PARTICIPANTS WITH NARCOLEPSY/NIGHTMARES Inclusion Criteria: * Diagnosis of narcolepsy type 1 or narcolepsy type 2 * Nightmare frequency of ≥1 times per week * Age 18 or older * Able to speak, read, and write in English * Live in the United States * Sleep and psychiatric medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study
Exclusion criteria
* Currently engaged in trauma- or sleep-related psychotherapy * Previous behavioral treatment for nightmares * Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment * Untreated moderate-severe sleep apnea PARTICIPANTS WHO ARE PARTNERS OF SOMEONE WITH NARCOLEPSY Inclusion Criteria: * Live with a romantic partner who meets the above criteria and has agreed to participate in the study * Age 18 or older * Able to speak, read, and write in English * Live in the United States
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Disturbing Dream and Nightmare Severity Index (DDNSI) | Completed at each of the three assessments (baseline, 10 weeks, 19 weeks) | The DDNSI is a questionnaire which measures the severity of nightmares. |
| Nightmare frequency (sleep diary) | Completed at each of the three assessments (baseline, 10 weeks, 19 weeks) | The number of nightmares experienced each day will be collected on daily sleep diaries completed during each assessment period. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PROMIS Anxiety | Completed at each of the three assessments (baseline, 10 weeks, 19 weeks) | Questionnaire which measures the severity of anxiety symptoms. |
| PROMIS Depression | Completed at each of the three assessments (baseline, 10 weeks, 19 weeks) | Questionnaire which measures the severity of depressive symptoms. |
Countries
United States